We are live on ! Find out more
CTOR

Citius Oncology
CTOR

23 hedge funds and large institutions have $62.6M invested in Citius Oncology in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

10% more capital invested

Capital invested by funds: $56.8M → $62.6M (+$5.82M)

5% more funds holding

Funds holding: 22 → 23 (+1)

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

Holders
23
Holders Change
+1
Holders Change %
+4.55%
% of All Funds
0.37%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
3
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Shaolin Capital Management
Florida
+$2.85M
2
KC
Kepos Capital
New York
+$2.4M
3
MSU
Mizuho Securities USA
New York
+$550K
4
CAC
Cowen and Company
New York
+$302K
5
PC
Periscope Capital
Ontario, Canada
+$81.4K

Top Sellers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$774K
2
KIM
Karpus Investment Management
New York
-$455K
3
VF
Virtu Financial
New York
-$323K
4
WAM
Wolverine Asset Management
Illinois
-$119K
5
CH
CVI Holdings
Delaware
-$21.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
WAM
1
Wolverine Asset Management
Illinois
$6.1M -$119K -11,133 -2%
KIM
2
Karpus Investment Management
New York
$5.82M -$455K -42,665 -7%
Hudson Bay Capital Management
3
Hudson Bay Capital Management
Connecticut
$5.38M – – –
MSU
4
Mizuho Securities USA
New York
$5.22M +$550K +51,557 +12%
GCL
5
Glazer Capital LLC
New York
$4.43M -$1.32K -124 -0%
PAMP
6
Polar Asset Management Partners
Ontario, Canada
$4.31M – – –
RCM
7
Rivernorth Capital Management
Florida
$3.77M – – –
PC
8
Periscope Capital
Ontario, Canada
$3.68M +$81.4K +7,623 +2%
KL
9
KIM LLC
Kansas
$3.5M – – –
WCMNY
10
Westchester Capital Management (New York)
New York
$3.22M – – –
SCM
11
Shaolin Capital Management
Florida
$2.87M +$2.85M +266,508 New
RCM
12
Radcliffe Capital Management
Pennsylvania
$2.44M – – –
KC
13
Kepos Capital
New York
$2.42M +$2.4M +225,000 New
CH
14
CVI Holdings
Delaware
$1.92M -$21.4K -2,000 -1%
Two Sigma Investments
15
Two Sigma Investments
New York
$1.62M – – –
WRBC
16
W.R. Berkley Corp
Connecticut
$1.52M +$52K +4,874 +4%
OCM
17
Oaktree Capital Management
California
$1.45M – – –
AA
18
AQR Arbitrage
Connecticut
$1.3M – – –
TAM
19
Terrapin Asset Management
Florida
$808K – – –
DWM
20
Dakota Wealth Management
Florida
$423K – – –
CAC
21
Cowen and Company
New York
$304K +$302K +28,263 New
VF
22
Virtu Financial
New York
$130K -$323K -30,290 -71%
TRCT
23
Tower Research Capital (TRC)
New York
$862 -$43 -4 -5%
Bank of Montreal
24
Bank of Montreal
Ontario, Canada
– -$774K -73,881 Closed
CS
25
Clear Street
New York
– -$74 -7 Closed

CTOR Hedge Fund Activity: Q3 2023 in Review

23 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Citius Oncology (CTOR) for Q3 2023, worth a combined $62.6M — up 10% from $56.8M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CTOR positions and 2 closed out — a net gain of 1 holder — while 3 added to existing stakes and 6 trimmed.

The largest buyer was Shaolin Capital Management, opening a new position worth an estimated $2.85M. The largest seller was Bank of Montreal, exiting entirely with an estimated $774K sold.

  • 23 institutional investors held Citius Oncology (CTOR) as of Q3 2023, up from 22 in Q2 2023.
  • Funds reported $62.6M of Citius Oncology stock for Q3 2023, up 10% quarter-over-quarter.
  • 3 funds opened new Citius Oncology positions in Q3 2023 and 2 closed out, a net change of +1 holder.
  • The largest Citius Oncology buyer in Q3 2023 was Shaolin Capital Management, an estimated $2.85M added.
  • The largest Citius Oncology seller in Q3 2023 was Bank of Montreal, an estimated $774K sold.

Based on aggregated 13F filings for Q3 2023.